The Anti-Vitiligo Effects of Feshurin In Vitro from Ferula samarcandica and the Mechanism of Action

Mayire Nueraihemaiti1,2, Zang Deng1, Khamidulla Kamoldinov3

  • 1State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, Key Laboratory of Chemistry of Plant Resources in Arid Regions, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China.

PubMed
Abstract

Insights

Feshurin, derived from Ferula samarcandica, promotes melanin production by activating the Wnt/β-catenin pathway and inhibits inflammation via the JAK-STAT pathway, showing potential as a novel vitiligo therapeutic.

Area of Science:

  • Pharmacology
  • Dermatology
  • Natural Products Chemistry

Background:

  • Vitiligo is a depigmentation disorder where Wnt/β-catenin signaling promotes melanogenesis.
  • The Janus kinase (JAK)-STAT pathway regulates inflammation by controlling chemokine (C-X-C motif) ligand 10 (CXCL10) secretion.
  • Ferula species have traditional uses, but their application in vitiligo is undocumented.

Purpose of the Study:

  • To investigate the potential of feshurin, a compound from Ferula samarcandica, as a therapeutic agent for vitiligo.

Main Methods:

  • Feshurin was isolated and its effects were analyzed using CCK-8, melanin content, tyrosinase activity, Western blotting, qRT-PCR, and ELISA.
  • Molecular docking was employed to verify the inhibitory effects of feshurin on JAK1.

Main Results:

  • Feshurin induced GSK-3β phosphorylation, leading to β-catenin nuclear translocation, MITF upregulation, and increased melanin production.
  • Feshurin inhibited CXCL10 production through the JAK-STAT pathway, confirmed by molecular docking.

Conclusions:

  • Feshurin demonstrates significant potential for developing novel therapeutics against vitiligo.

Related Concept Videos